EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Correcting a patient-specific Rhodopsin mutation with adenine base editor in a mouse model

Xiaoxue He, Tong Yan, Zongming Song, Lue Xiang, Jiayang Xiang, Yeqin Yang, Kaiqun Ren, Jicheng Bu, Xilin Xu, Zhuo Li, Xiaowei Guo, Bin Lin und 3 weitere

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.03.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Xiaoxue He und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, Engineering Research Center of …. Hauptthemen laut MEDLINE: Gene Editing, Adenine, Retinitis Pigmentosa, Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan Province Natural Science Foundation, National Natural Science Foundation of China, National Major Science and Technology Projects of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome editing offers a great promise to treating human genetic diseases. To assess genome-editing-mediated therapeutic effects in vivo, an animal model is indispensable. The genomic disparities between mice and humans often impede the direct clinical application of genome-editing-mediated treatments using conventional mouse models. Thus, the generation of a mouse model with a humanized genomic segment containing a patient-specific mutation is highly sought after for translational research. In this study, we successfully developed a knockin mouse model for autosomal-dominant retinitis pigmentosa (adRP), designated as hT17M knockin, which incorporates a 75-nucleotide DNA segment with the T17M mutation (Rhodopsin-c.C50T; p.T17M). This model demonstrated significant reductions in electroretinogram amplitudes and exhibited disruptions in retinal structure. Subsequently, we administered an adeno-associated virus vectors carrying an adenine base editor (ABE) and a single-guide RNA specifically targeting the T17M mutation, achieving a peak correction rate of 39.7% at the RNA level and significantly improving retinal function in ABE-injected mice. These findings underscore that the hT17M knockin mouse model recapitulates the clinical features of adRP patients and exhibits therapeutic effects with ABE-mediated treatments. It offers a promising avenue for the development of gene-editing therapies for RP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingAdenineRetinitis PigmentosaMutationRhodopsinAnimalsDisease Models, AnimalMiceHumansGene Knock-In TechniquesDependovirusGenetic VectorsElectroretinographyRNA, Guide, CRISPR-Cas SystemsCRISPR-Cas SystemsRetinaGenetic Therapy

Stichwörter der Autor:innen

adenine base editorgene editinggene therapymiceretinitis pigmentosarhodopsin

Substanzen

AdenineRhodopsinRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Changsha, H…
  • School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, State Key Laboratory and Key Laboratory of Vision Science, Ministry of Health and Zhejiang Provincial Key Laboratory of Ophthalmology and…
  • Henan Eye Hospital, Henan Eye Institute, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University and People's Hospital of Henan University, Zhengzhou, Henan 450003, China.
  • School of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
  • Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central…
  • School of Optometry, Hong Kong Polytechnic University, Hong Kong HJ502, China.

Förderung

  • Henan Province Natural Science Foundation
  • National Natural Science Foundation of China
  • National Major Science and Technology Projects of China
  • Major Science and Technology Project of Hainan Province
  • Hunan Normal University
  • Hunan Provincial Natural Science Foundation
  • Chinese Academy of Sciences
  • National Key Research and Development Program of China

Zitieren

APA

He, X., Yan, T., Song, Z., Xiang, L., Xiang, J., Yang, Y., Ren, K., Bu, J., Xu, X., Li, Z., Guo, X., Lin, B., Zhou, Q., Lin, G., & Gu, F. (2025). Correcting a patient-specific Rhodopsin mutation with adenine base editor in a mouse model. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.03.021

Vancouver

He X, Yan T, Song Z, Xiang L, Xiang J, Yang Y, et al. Correcting a patient-specific Rhodopsin mutation with adenine base editor in a mouse model. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.03.021

BibTeX
@article{He2025,
  author = {He, Xiaoxue and Yan, Tong and Song, Zongming and Xiang, Lue and Xiang, Jiayang and Yang, Yeqin and Ren, Kaiqun and Bu, Jicheng and Xu, Xilin and Li, Zhuo and Guo, Xiaowei and Lin, Bin and Zhou, Qinghua and Lin, Ge and Gu, Feng},
  title = {Correcting a patient-specific Rhodopsin mutation with adenine base editor in a mouse model},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.03.021}
}
Kostenlos starten →